What's in Shanghai Shyndec Pharmaceutical Co., Ltd.'s pipeline?

Shanghai Shyndec Pharmaceutical Co., Ltd. has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Shanghai Shyndec Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Bayer, Beijing Tiantan Hospital, GlaxoSmithKline, Guangzhou First People's Hospital, Organon and Co.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shanghai-shyndec-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Shanghai Shyndec Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shanghai Shyndec Pharmaceutical Co., Ltd. pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
nifedipine CR tablets (Adalat)	nifedipine CR tablets (Adalat)	marketed	Calcium channel blocker (dihydropyridine)	L-type voltage-gated calcium channel	Cardiovascular
Adalat	Adalat	marketed			Other

Therapeutic area mix

Cardiovascular · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Beijing Tiantan Hospital · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Guangzhou First People's Hospital · 1 shared drug class
Organon and Co · 1 shared drug class
Peking University First Hospital · 1 shared drug class
Pfizer Inc. · 1 shared drug class
SK Chemicals Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shanghai Shyndec Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Shanghai Shyndec Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shanghai-shyndec-pharmaceutical-co-ltd. Accessed 2026-05-16.